A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

NCT04135508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: BAT1406
DRUG: Humira

Sponsor

Bio-Thera Solutions